Literature DB >> 28284242

Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle.

Thibaut Deschamps1,2,3,4,5, Quentin Bazot4,2,1,6,3,5, Derek M Leske7,8, Ruth MacLeod8, Dimitri Mompelat9,5,1,4,3,2, Lionel Tafforeau10,5,11,1, Vincent Lotteau1,4,2,5,10, Vincent Maréchal12, George S Baillie8, Henri Gruffat2,5,1,3,4, Joanna B Wilson8, Evelyne Manet5,1,3,4,2.   

Abstract

The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is a sequence-specific DNA-binding protein that plays an essential role in viral episome replication and segregation, by recruiting the cellular complex of DNA replication onto the origin (oriP) and by tethering the viral DNA onto the mitotic chromosomes. Whereas the mechanisms of viral DNA replication are well documented, those involved in tethering EBNA1 to the cellular chromatin are far from being understood. Here, we have identified regulator of chromosome condensation 1 (RCC1) as a novel cellular partner for EBNA1. RCC1 is the major nuclear guanine nucleotide exchange factor for the small GTPase Ran enzyme. RCC1, associated with chromatin, is involved in the formation of RanGTP gradients critical for nucleo-cytoplasmic transport, mitotic spindle formation and nuclear envelope reassembly following mitosis. Using several approaches, we have demonstrated a direct interaction between these two proteins and found that the EBNA1 domains responsible for EBNA1 tethering to the mitotic chromosomes are also involved in the interaction with RCC1. The use of an EBNA1 peptide array confirmed the interaction of RCC1 with these regions and also the importance of the N-terminal region of RCC1 in this interaction. Finally, using confocal microscopy and Förster resonance energy transfer analysis to follow the dynamics of interaction between the two proteins throughout the cell cycle, we have demonstrated that EBNA1 and RCC1 closely associate on the chromosomes during metaphase, suggesting an essential role for the interaction during this phase, perhaps in tethering EBNA1 to mitotic chromosomes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28284242     DOI: 10.1099/jgv.0.000681

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

Review 1.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

Review 2.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

3.  Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus.

Authors:  Kyoung-Dong Kim; Hideki Tanizawa; Alessandra De Leo; Olga Vladimirova; Andrew Kossenkov; Fang Lu; Louise C Showe; Ken-Ichi Noma; Paul M Lieberman
Journal:  Nat Commun       Date:  2020-02-13       Impact factor: 14.919

4.  RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases.

Authors:  Yuxiang Deng; Long Yu; Yujie Zhao; Jianhong Peng; Yanbo Xu; JiaYi Qin; Binyi Xiao; Songran Liu; Mei Li; Yujing Fang; Zhizhong Pan
Journal:  Pathol Oncol Res       Date:  2021-12-02       Impact factor: 3.201

Review 5.  EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.

Authors:  Joanna B Wilson; Evelyne Manet; Henri Gruffat; Pierre Busson; Marc Blondel; Robin Fahraeus
Journal:  Cancers (Basel)       Date:  2018-04-06       Impact factor: 6.639

6.  Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.

Authors:  Sana AlQarni; Yazeed Al-Sheikh; Donald Campbell; Mark Drotar; Adele Hannigan; Shelagh Boyle; Pawel Herzyk; Andrew Kossenkov; Kate Armfield; Lauren Jamieson; Mariarca Bailo; Paul M Lieberman; Penelope Tsimbouri; Joanna B Wilson
Journal:  Oncogene       Date:  2018-04-25       Impact factor: 9.867

7.  STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency.

Authors:  Yuyan Wang; Shujuan Du; Caixia Zhu; Chong Wang; Nuoya Yu; Ziqi Lin; Jin Gan; Yi Guo; Xinxin Huang; Yuping He; Erle Robertson; Di Qu; Fang Wei; Qiliang Cai
Journal:  PLoS Pathog       Date:  2020-03-16       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.